Does Rallies show 13F holders for PBM?

Yes. Rallies tracks hedge fund and 13F ownership data for PBM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PBM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PBM. It does not provide personalized investment advice.

PBM (Psyence Biomedical Ltd. Common Shares) Stock Analysis - Hedge Fund Holdings

Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of May 21, 2026, PBM trades at $4.00 with a market cap of $10.57M and a P/E ratio of 0.00. PBM moved +2.56% today. Year to date, PBM is -19.70%; over the trailing twelve months it is -89.32%. Its 52-week range spans $1.92 to $515.56. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PBM stock?

Hedge funds tracked by Rallies that own PBM include Two Sigma and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Psyence Biomedical Ltd. Common Shares.

PBM Key Metrics

Key financial metrics for PBM
Metric	Value
Price	$4.00
Market Cap	$10.57M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$515.56
52-Week Low	$1.92
Volume	1.19K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding PBM

Two Sigma holds 14.99K shares of PBM, changed -73.13% as of Sep 30, 2024.
Citadel Advisors holds 11.49K shares of PBM, changed -93.21% as of Dec 31, 2024.

Latest PBM News

Psyence BioMed Schedules U.S. Outreach on GMP Ibogaine Manufacturing from African Facility — May 15, 2026
Psyence BioMed Doses First Patient in 25mg Psilocybin Phase IIb Trial — Apr 23, 2026
Psyence BioMed Secures GMP-Compliant Ibogaine Supply Chain With African Source Platform — Apr 20, 2026
Psyence BioMed Emphasizes GMP Ibogaine Manufacturing as U.S. Prepares Regulatory Action — Apr 17, 2026
Pacific Bay Minerals, Aurwest Sign 50% Weaver Gold JV with $15K–$25K Tiered Cash Payments — Apr 14, 2026

PBM Analyst Consensus

PBM analyst coverage data. Average price target: $0.00.

Common questions about PBM

Who owns PBM stock?: Hedge funds tracked by Rallies that own PBM include Two Sigma and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Psyence Biomedical Ltd. Common Shares.
Does Rallies show 13F holders for PBM?: Yes. Rallies tracks hedge fund and 13F ownership data for PBM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PBM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PBM. It does not provide personalized investment advice.